Objective: Emergency lower extremity embolectomy is a common vascular surgical procedure that has poorly defined outcomes. Our goal was to define the perioperative morbidity for emergency embolectomy and develop a risk prediction model for perioperative mortality.
Acute limb ischemia (ALI) secondary to a thromboembolic event is a common vascular surgery emergency, often occurring in elderly patients with multiple comorbidities. 1 ALI is characterized by a sudden loss in perfusion in the lower extremity that can be both limb and life threatening. 2 Surgical treatment for a thromboembolic event that is not secondary to in situ thrombosis, such as seen in acute-on-chronic occlusive disease, is often by an open thromboembolectomy. 3 The prognosis of ALI caused by thromboembolism is poor, even with early intervention, with 30-day mortality rates of 7% to 18%. 4, 5 Although mortality rates have been reported, data documenting the risk factors associated with both postoperative mortality and major morbidity are lacking. Available data include heterogenous populations consisting of patients with both acute-on-chronic disease and acute embolic events, and many studies are small and from a single center. 4, 5 Our goal was to establish benchmark rates of postoperative morbidity and mortality after lower extremity embolectomy for ALI using a multi-institutional contemporary analysis of a large cohort of patients. Our secondary goal was to develop a mortality predictive risk score that could be used as a quantifiable assessment of outcomes to guide discussion about informed consent and shared decision making for surgeons, patients, and their surrogates.
METHODS
The Boston University Institutional Review Board approved this study. Patient consent was waived.
Patient selection. The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) is a multicenter database for surgeons providing outcomes that are risk-adjusted and prospective. More than 250 participating centers report morbidity and mortality outcomes for patients undergoing a wide range of surgical procedures. Members have access to >135 variables and patient-level demographics through the Participant User Files, a resource with data gathering, sampling, and structure that has been validated in prior studies. [6] [7] [8] [9] [10] The ACS NSQIP and the hospitals participating in the ACS NSQIP are the source of the data used in this report. They have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors. We used ACS NSQIP Participant User Files to identify all patients undergoing emergency lower extremity embolectomy for ALI after a thromboembolic event from 2005 to 2012. The analysis excluded patients with previous critical limb ischemia based on the rest pain/tissue loss variable in the database to minimize the subset of patients with chronic disease. Bilateral embolectomy was also eliminated to exclude patients with a potential aortic occlusion. To further isolate unilateral embolectomy outcomes, the need for bypass was excluded to avoid confounding of postoperative outcomes. Concurrent bypass and nonemergency cases were also excluded. Patients undergoing embolectomy were identified by Current Procedural Terminology (American Medical Association, Chicago, Ill) codes 34201 and 34203, corresponding to an embolectomy of the iliofemoral-popliteal arteries and popliteal-tibial-peroneal arteries, respectively. A separate Current Procedural Terminology code for an ankle incision for distal tibial embolectomy is not available.
Variables and outcome definitions. The primary outcome that was analyzed was 30-day mortality. Secondary outcomes included composite cardiac complications defined by the Revised Cardiac Risk Index to include myocardial infarction (MI) and cardiac arrest, pulmonary complications (composite reintubation, pneumonia, prolonged intubation), any wound complication (superficial surgical site infections [SSI] , deep SSI, non-SSIs, organ space SSI, or wound dehiscence), return to the operating room, length of stay, and readmission. 11 Demographic variables considered included age, sex, race, and preoperative independent, partially dependent, or totally dependent functional status, as defined by a patient's ability to perform activities of daily living. Body mass index was separated into nonobese and obese categories. Coexistent medical conditions included diabetes, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), dyspnea, history of transient ischemic attack/stroke, recent MI or unstable angina, hypertension, renal disease, and use of steroids.
Statistical analysis. Sample characteristics and primary and secondary outcomes are described using means and standard deviations for continuous variables and as counts and percentages for categoric variables. Logistic regression was used to assess demographic characteristics, medical history, and procedure characteristics were assessed individually as potential predictors of 30-day mortality. The associations are expressed with odds ratios (OR) and corresponding 95% confidence intervals (CI). Demographic factors and variables significantly associated with 30-day mortality at the P ¼ .2 level were considered in the prediction model. Backward elimination procedure with a .2 significance level to stay in the model was used to construct the parsimonious prediction model. Model discriminative ability was assessed, and C statistics with the corresponding 95% CIs are reported. Internal validation was used to calculate the C statistic adjusted for optimism. Model fit was assessed using Hosmer-Lemeshow goodness-of-fit test. A calibration plot was constructed to compare observed and predicted 30-day mortality. To simplify the use of the risk algorithm in clinical practice, the prediction model was used to develop a scoring scheme using the method described by Sullivan et al. 12 Statistical analyses were performed using SAS 9.3 software (SAS Institute Inc, Cary, NC).
RESULTS
We identified 1749 embolectomies from 2005 to 2012 that met our inclusion and exclusion criteria. Iliofemoral-popliteal embolectomy was performed in 1231 patients (70.4%), popliteal-tibioperoneal embolectomy in 303 (17.3%), and at both levels in 215 (12.3%). The etiology of these thromboembolic events was not described in the database. Fasciotomies were performed ARTICLE HIGHLIGHTS (Fig 1) .
The mortality risk prediction model at 30 days included eight factors associated with 30-day mortality: advanced age, male gender, functional dependence, use of steroids, and history of CHF, COPD, MI/angina, and chronic renal insufficiency, as described in the Methods. The model showed good discrimination (C ¼ 0.769; 95% CI, 0.733-0.806), with the optimism adjusted to C ¼ 0.762. The Hosmer-Lemeshow goodness-of-fit test was P ¼ .966, indicating good fit. The probability of 30-day mortality predicted by the model was similar to observed (Fig 2) .
The model was used to develop a risk prediction score to allow for a simple numeric stratification of patients by their preoperative risk factors. Each risk factor included into the prediction model was assigned points corresponding to its relative contribution to prediction of postoperative death, determined by the model coefficient. These points are added for each patient to compute the risk score. Depending on the risk scores, patients were categorized into low-, moderate-low-, moderate, moderate-high-, and high-risk groups. Functional dependence and chronic renal insufficiency were the highest values. A score >11 corresponded to a 30-day mortality of 50% (Table II) . 
DISCUSSION
Our study suggests that in patients with ALI requiring embolectomy, functional status, advanced age, recent MI/angina, use of steroids for a chronic condition, chronic renal insufficiency, CHF, COPD, and male gender, were associated with higher rates of postoperative death.
Poor preoperative functional dependence, advanced age, and cardiac comorbidities have been shown to be independently associated with higher risk of adverse outcomes and resource utilization in other vascular surgery patients, such as those undergoing lower extremity bypass. 10, [13] [14] [15] The results in our study were similar. Nearly half of the patients who died postoperatively had total functional dependence, an outcome that is congruent with prior studies in vascular and nonvascular surgery patients.
10,16
Chronic steroid use has been associated with a high rate of postoperative complications and death in a wide array of surgical procedures. 17, 18 This is most likely due to susceptibility to infection and impaired healing postoperatively. Our study shows similar results, with patients receiving steroid therapy experiencing a higher rate of postoperative mortality. Patients with renal failure are also widely known to have higher rates of postoperative morbidity and mortality. 19, 20 Our study yielded parallel results, with significant association between chronic renal insufficiency and the outcome of postoperative mortality. Historically, patients with heart failure have higher rates of postoperative mortality. The rate of postoperative mortality in this subset is cited as up to 11% and is higher than in control groups in some studies of patients undergoing noncardiac abdominal, orthopedic, thoracic, and vascular operations. 21, 22 Our findings suggest patients with heart failure face a significantly higher risk in the postoperative period as well. COPD has also been shown to be an independent risk predictor for in-hospital death in major surgical interventions. 23, 24 Here we note a similar trend. Although historically the influence of female gender has been most often associated with poorer outcomes given the higher incidence of disease requiring intervention, our study found a higher mortality among men. 25 This may partly be explained by the fact that most studies have analyzed vascular disease for elective cases, whereas the emergent nature studied here may not be comparable.
With the findings in this study, we have created a novel scoring system to quantify postoperative mortality after emergency embolectomy based on comorbidities and demographic factors. This is important to help guide informed consent discussions and surgical decision making for patients and surgeons, respectively. A key part of the surgical informed consent process necessitates defining code status, advanced directives, and patient goals of care. 26, 27 This requires patient and physician discussions that clearly define medical preferences and facilitate patient autonomy. [28] [29] [30] By combining the goals of care with the potential benefits vs risks for undergoing the procedure, a surgeon can offer an optimal plan for treatment. This scoring system would not serve as grounds to refuse an operative intervention but would allow physicians and patients to consider alternative treatment decisions, such as providing palliative or end of life care, when the complication rate is predicted to be very high. These data can also be used to compare baseline embolectomy outcomes to newer percutaneous embolectomy devices.
Our study has certain limitations. It is retrospective, and as a result, the variables we analyzed were limited and predefined. The data are not comprehensive enough to include every demographic, intraoperative variable, surgeon-specific outcome, duration of ischemia, and anatomic variant in each patient presentation, which may result in a degree of confounding. The ACS NSQIP database provides a large sample for data analysis that that can be used as a quality improvement tool to define preoperative and post-operative outcomes in a 30-day period, but does not provide long-term outcomes. Although wound complications and major causes of mortality are likely to occur #30 days, any event beyond this time would not be accounted for or assessed. Furthermore, the database gives an overall readmission rate in this population, but the reason for and time frame of this complication is not available.
Also, the specific circumstances leading to the embolic event and vascular emergency are not outlined in the ACS NSQIP database. ACS NSQIP informs us if a reoperation occurs, but the specific operation is not identified; therefore, whether there were any amputations during the index admission is unclear. However, of the patients undergoing embolectomy, 74.3% did not return to the operating room after the initial intervention. We do not have anatomic details aside from embolectomy location; however, anatomic details are often not known in these cases. Also, data on endovascular embolectomy interventions are not available in this database.
CONCLUSIONS
This study identifies specific risk factors associated with morbidity and mortality after emergency lower extremity embolectomy and creates an evidence base for creation of a risk prediction model to help stratify patients preoperatively. It also establishes baseline data to compare newer catheter-based embolectomy products. This is meant to help vascular surgeons improve not only their surgical decision making but also the informed consent discussion with patients and their families.
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